Skip to main content
AM

Atrility Medical

The startup develops a cardiac monitoring device that provides continuous atrial electrograms for the diagnosis of atrial arrhythmias. This technology enables healthcare providers to enhance patient outcomes by facilitating real-time monitoring and treatment of these conditions.

Madison, United StatesFounded 201711200+ followers
Updated 3 months ago

Funding

$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Post-operative arrhythmias are common, especially in pediatric patients, and can lead to significant morbidity and mortality. Diagnosing these arrhythmias using surface leads on bedside monitors can be challenging due to poor P-wave identification. Current methods for obtaining atrial electrograms are time-consuming and provide only a short-term view, potentially delaying diagnosis and treatment.

Solution

Atrility Medical's AtriAmp provides continuous atrial electrograms by connecting temporary atrial pacing wires to a bedside monitor, allowing real-time viewing and retrospective analysis of intracardiac atrial electrocardiograms. This facilitates accurate and confident diagnosis of atrial arrhythmias, enabling timely treatment and potentially improving patient outcomes. The AtriAmp improves workflow by providing continuous access to atrial electrograms, eliminating the need for temporary atrial ECGs and saving time for ICU staff.

Target Audience

The primary target audience includes ICU cardiologists, electrophysiologists, nurses, and other healthcare providers who monitor patients for post-operative arrhythmias, particularly in pediatric cardiac intensive care units.

Features

  • Provides continuous, real-time atrial electrograms on standard patient monitors.
  • Compatible with a wide range of patient monitor ECG modules, external temporary pacemakers, and epicardial wires.
  • Allows for retrospective analysis through historical monitor signal review.
  • FDA cleared for both pediatric and adult patients.
  • Facilitates simultaneous pacing and monitoring.
This profile is AI-generated and may contain inaccuracies.